Editorial for exploring understudied inflammatory diseases
C/EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastoma
Microbial production of short-chain fatty acids attenuates long-term neurologic impairment after traumatic brain injury
Targeting Tumor-Infiltrating Immune Cells for Targeted Alpha Therapy in Gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b Dosing through PET Imaging
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy
NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastases
The T cell receptor landscape of childhood brain tumors
Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts
Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM
Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastoma
Preprint
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors
A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets
Immunotherapy for pediatric low-grade gliomas
Myeloid cells as potential targets for immunotherapy in pediatric gliomas
ImmunoPET imaging of TIGIT in the glioma microenvironment
Glioblastoma vaccines: past, present, and opportunities
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis
Endogenous Interleukin-17a Contributes to Normal Spatial Memory Retention but Does Not Affect Early Behavioral or Neuropathological Outcomes after Experimental Traumatic Brain Injury
Immunoregulation via Cell Density and Quorum Sensing-like Mechanisms: An Underexplored Emerging Field with Potential Translational Implications
Tim-3 mediates T cell trogocytosis to limit antitumor immunity
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis
Noncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen
Memory CD4 T Cells in Immunity and Autoimmune Diseases
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells
The Alzheimer’s Disease-Associated Protein BACE1 Modulates T Cell Activation and Th17 Function
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival
Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4
Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis
Early response index: a statistic to discover potential early stage disease biomarkers
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Microwave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis
Microwave and magnetic (M2) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis
Stability of T-cell lineages in autoimmune diseases
Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis
Also on
